US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
“Global Breast Cancer Drugs Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by Trusted Business Insights. The global breast cancer drugs market report has been segmented on the basis of product type, technology and region.
Request Covid - 19 ImpactGlobal Breast Cancer Drugs Market: Overview Breast cancer is a type of cancer, that can occur more in women than in men. Some of the symptoms of the disease include bloody secretion from the nipple, a lump or block in the breast, and differences in the texture or shape of the nipple or breast. The treatment of breast cancer is depending on the stage of cancer. In addition, its treatment can consist of radiation, hormone therapy, chemotherapy, and surgery. Early detection of breast cancer is key to effective treatment of the disease. Also, early exposure of disease can lead to better outcomes including a number of treatment options, improved survival rate, and changed quality of life. There exist a rising pressure and demand for novel therapies or treatment owing to the rapidly growing prevalence of diseases. The strong pipeline is projected to provide effective and new treatment options and upgraded outcomes than already existing therapies. Global Breast Cancer Drugs Market: Dynamics The growing prevalence of the disease coupled with emerging and better novel therapies are some factors likely to fuel the global market growth. Global breast cancer drugs market is estimated to grow lucratively attributable to many major players are focusing on Research & Development of new and innovative treatments. They involve extensive research in order to develop novel drugs for the treatment of this disease to gain a higher market share. Various target and specific therapies have been designed and customized along with various advancements in drug delivery systems. However, aging is taken as one of the extreme risk factors for breast cancer. In addition, according to Cancer Treatment Centers of America, most women of age above 60 years are more likely to be diagnosed with cancer, whereas only around 10% to 15% of cancer cases occur in women of age 45 or less than 45 years. High prevalence of this disease along with patent expiry are some other factors that are influencing government and private investment in research and development activities of new products. Global Breast Cancer Drugs Market: Segment Analysis The HER2 inhibitors segment is expected as the most lucrative segment of the global market. The rising incidence of HER2 positive breast cancer is the major reason behind the growth of this segment. Furthermore, the CDK 4/6 inhibitor segment is projected to grow at the fastest rate of growth during the forecast period. The aforesaid drugs are anticipated to increase the survival rate of patients suffered from metastatic breast cancer. Additionally, advancement and innovation of novel drugs, such as Verzenio launched by Eli Lilly and Company and Kisqali launched by Novartis AG and is estimated to drive growth of this segment in the upcoming years. Global Breast Cancer Drugs Market: Regional Analysis Rising awareness and high presence of established players coupled with R&D infrastructure are some factors that are contributing to the high growth of the North America Market. On the other hand, the Asia Pacific market is anticipated to witness the fastest CAGR over the forecast years. The rapid growth in the global demand for oncology drugs has prompted major drug providers and manufacturers to set up their manufacturing and R&D facilities in this region. Additionally, initiatives taken by numerous organizations in order to create people more aware and raise funds for the treatment of disease is projected to feed the regional market growth.
Global Breast Cancer Drugs Market Segmentation:Segmentation by Drug Type: HER2 inhibitor Mitotic inhibitor Anti-metabolites Aromatase inhibitor CDK 4/6 inhibitor Hormonal receptor
Table of Contents Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data SourcesChapter 2. Executive SummaryChapter 3. Global Breast Cancer Drugs Market Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects, 2016 - 2027 3.3. Value Chain Analysis 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis | read more...